BNTX · NASDAQ
BioNTech SE (BNTX) Stock Price & Fundamentals
$760.61−0.26%−$1.97End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
BioNTech SE (BNTX) closed at $760.61 on Oct 9, 2026, down 0.26% from the previous close of $762.58.
Share price, past year
1Y +8.65%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $760.61 |
| Sep 30, 2026 | $773.36 |
| Aug 31, 2026 | $775.58 |
| Jul 31, 2026 | $781.31 |
| Jun 30, 2026 | $812.25 |
| May 29, 2026 | $762.72 |
| Apr 30, 2026 | $751.66 |
| Mar 31, 2026 | $792.78 |
| Feb 27, 2026 | $744.39 |
| Jan 30, 2026 | $720.97 |
| Dec 31, 2025 | $698.74 |
| Nov 28, 2025 | $733.97 |
| Oct 31, 2025 | $710.55 |
Key statistics
- 52-week range
- $691.45 – $812.25
Financials
BioNTech SE's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Company profile
- Name
- BioNTech SE
- Ticker
- BNTX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- An Der Goldgrube 12, Mainz, 2M 55131
- Incorporated in
- 2M
- Fiscal year ends
- December
- SEC CIK
- 0001776985
Frequently asked questions
What is BioNTech SE's stock price?
BioNTech SE (BNTX) closed at $760.61 on Oct 9, 2026, down 0.26% from the previous close of $762.58.
Sources and methodology
Fundamentals come from BioNTech SE's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures